FDA-cleared profile

Aplio i900, Aplio i800 and Aplio i700 Software V9.0 Diagnostic Ultrasound System

Canon Medical Systems Corporation · Ultrasound · FDA-cleared (510(k))

Authorized purpose: Aplio i900, i800, and i700 software V9.0 are mobile diagnostic ultrasound systems for multi-region imaging. K252074 adds deep-learning 3rd Harmonic Imaging for abdominal images; with specified endoscopic transducers, the Aplio i800/E3 also supports imaging of the upper gastrointestinal tract, surrounding organs, airways, tracheobronchial tree, and esophagus.

Clinical role
Supports standard diagnostic ultrasound acquisition and review. V9.0 adds deep-learning 3rd Harmonic Imaging for abdominal image filtering, SMI Angio Mode for separating adjacent blood flows, Precision+ Fine Processing for border depiction, Auto Tune pre-scanning for shear-wave acquisition, and expanded endoscopic ultrasound support on the Aplio i800/E3.
Images and patients
Ultrasound · Multi-region
Key limitation
Keep in mind: The 3rd Harmonic Imaging evaluation used images from 30 U.S. patients at one site and assessed image quality rather than diagnostic accuracy or patient outcomes. Endoscopic indications require the specified Aplio i800/E3 and transducer configurations. Feature availability depends on the installed model, probes, and licensed options.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Aplio i900, i800, and i700 software V9.0 are mobile diagnostic ultrasound systems for multi-region imaging. K252074 adds deep-learning 3rd Harmonic Imaging for abdominal images; with specified endoscopic transducers, the Aplio i800/E3 also supports imaging of the upper gastrointestinal tract, surrounding organs, airways, tracheobronchial tree, and esophagus.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Multi-region Input: Ultrasound images and Doppler or elastography data acquired with compatible Aplio i900, i800, or i700 probes operating at approximately 2 to 33 MHz; 3rd Harmonic Imaging processes abdominal images, while specified endoscopic workflows use GF-UCT180 or BF-UC190F transducers on the Aplio i800/E3.
  • Who uses it?Intended users: Physicians and appropriately trained healthcare professionals.
  • What does the software produce?Output: Diagnostic ultrasound images and measurements plus enhanced abdominal images from 3rd Harmonic Imaging, emphasized adjacent-flow displays from SMI Angio Mode, fine-processed border displays, optimized shear-wave acquisitions, and specified gastrointestinal or airway endoscopic ultrasound images for qualified-user review.
  • What is its most important limitation?Key limitation: The 3rd Harmonic Imaging evaluation used images from 30 U.S. patients at one site and assessed image quality rather than diagnostic accuracy or patient outcomes. Endoscopic indications require the specified Aplio i800/E3 and transducer configurations. Feature availability depends on the installed model, probes, and licensed options.

Clinical takeaway. Clinical role: Aplio i900, i800, and i700 software V9.0 are mobile diagnostic ultrasound systems for multi-region imaging. K252074 adds deep-learning 3rd Harmonic Imaging for abdominal images; with specified endoscopic transducers, the Aplio i800/E3 also supports imaging of the upper gastrointestinal tract, surrounding organs, airways, tracheobronchial tree, and esophagus.

Evidence takeaway. Evidence from the reviewed source record: FDA-reviewed support includes a manufacturer-sponsored, single-site, blinded image-quality study for 3rd Harmonic Imaging plus phantom and small-volunteer studies for other V9.0 features. The submission does not report diagnostic-accuracy or patient-outcome endpoints.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Aplio i900, i800, and i700 software V9.0 are mobile diagnostic ultrasound systems for multi-region imaging. K252074 adds deep-learning 3rd Harmonic Imaging for abdominal images; with specified endoscopic transducers, the Aplio i800/E3 also supports imaging of the upper gastrointestinal tract, surrounding organs, airways, tracheobronchial tree, and esophagus.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Workflow role
Supports standard diagnostic ultrasound acquisition and review. V9.0 adds deep-learning 3rd Harmonic Imaging for abdominal image filtering, SMI Angio Mode for separating adjacent blood flows, Precision+ Fine Processing for border depiction, Auto Tune pre-scanning for shear-wave acquisition, and expanded endoscopic ultrasound support on the Aplio i800/E3.
  • Exact FDA submission
  • Checked 2026-09-02
Required input
Ultrasound images and Doppler or elastography data acquired with compatible Aplio i900, i800, or i700 probes operating at approximately 2 to 33 MHz; 3rd Harmonic Imaging processes abdominal images, while specified endoscopic workflows use GF-UCT180 or BF-UC190F transducers on the Aplio i800/E3.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Output and clinician action
Diagnostic ultrasound images and measurements plus enhanced abdominal images from 3rd Harmonic Imaging, emphasized adjacent-flow displays from SMI Angio Mode, fine-processed border displays, optimized shear-wave acquisitions, and specified gastrointestinal or airway endoscopic ultrasound images for qualified-user review.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Care setting
Hospital and clinical environments performing diagnostic ultrasound; specified Aplio i800/E3 configurations also support endoscopic ultrasound workflows.
  • Exact FDA submission
  • Checked 2026-09-02
Intended users
Physicians and appropriately trained healthcare professionals.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Limitations
The 3rd Harmonic Imaging evaluation used images from 30 U.S. patients at one site and assessed image quality rather than diagnostic accuracy or patient outcomes. Endoscopic indications require the specified Aplio i800/E3 and transducer configurations. Feature availability depends on the installed model, probes, and licensed options.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Evidence summary
FDA-reviewed support includes a manufacturer-sponsored, single-site, blinded image-quality study for 3rd Harmonic Imaging plus phantom and small-volunteer studies for other V9.0 features. The submission does not report diagnostic-accuracy or patient-outcome endpoints.
  • Exact FDA submission
  • Checked 2026-09-02

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA-reviewed support includes a manufacturer-sponsored, single-site, blinded image-quality study for 3rd Harmonic Imaging plus phantom and small-volunteer studies for other V9.0 features. The submission does not report diagnostic-accuracy or patient-outcome endpoints.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-02
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K252074 3rd Harmonic Imaging blinded observer study

  • DesignManufacturer-sponsored blinded image-quality comparison of 3rd Harmonic Imaging with conventional second-harmonic imaging using three U.S. board-certified radiologists and a five-point ordinal scale
  • PopulationAt least 294 abdominal images from 30 patients at one U.S. site; ages 23 to 89 years, approximately balanced sex, BMI 18.5 to 36.3 kg/m2, and representative abdominal structures and focal pathologies
  • Scopeexact submission
  • Tested versionK252074 3rd Harmonic Imaging on Aplio i900, i800, and i700 software V9.0
  • Samplen=30
  • Sites1
  • IndependenceSponsor or vendor study

K252074

The locked validation dataset was independent of training data. Scores were above the neutral midpoint for three image-quality domains, but effect sizes, diagnostic accuracy, and patient outcomes were not reported.

K252074 supporting feature and phantom validation

  • DesignManufacturer phantom and volunteer-image verification for SMI Angio Mode, Auto Tune, Precision+ Fine Processing, and 3rd Harmonic Imaging
  • PopulationPhantom data, images from three volunteers for SMI Angio Mode, thyroid and liver images from three volunteers for Auto Tune, representative clinical images for Precision+, and five abdominal phantoms for 3rd Harmonic Imaging
  • Scopeexact submission
  • Tested versionAplio i900, i800, and i700 software V9.0
  • IndependenceSponsor or vendor study

K252074

Regulatory feature verification; it does not establish diagnostic accuracy, comparative clinical outcomes, or local-site performance.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Ultrasound images and Doppler or elastography data acquired with compatible Aplio i900, i800, or i700 probes operating at approximately 2 to 33 MHz; 3rd Harmonic Imaging processes abdominal images, while specified endoscopic workflows use GF-UCT180 or BF-UC190F transducers on the Aplio i800/E3.

    Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-19 · FDA K252074: Aplio i900, Aplio i800 and Aplio i700 Software V9.0 Diagnostic Ultrasound System

  2. Routing

    Source context, not route validation: The system is an on-premises ultrasound platform with site-network image exchange. Canon's current interoperability page lists an IHE integration statement for Aplio i700, i800, and i900 software V6.0 or later, covering V9.0.

    Scope: Exact product version. Confirm the installed IHE statement, DICOM services, endoscopic-video workflow, network routing, and downstream object support.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-02 · FDA K252074: Aplio i900, Aplio i800 and Aplio i700 Software V9.0 Diagnostic Ultrasound System · IHE integration statements for current Canon ultrasound products

  3. AI processing

    Source context, not route validation: On-premises mobile Aplio i900, i800, or i700 ultrasound console running software V9.0 on Windows 11 LTSC; endoscopic imaging requires the specified Aplio i800/E3 configuration and transducer.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-02 · FDA K252074: Aplio i900, Aplio i800 and Aplio i700 Software V9.0 Diagnostic Ultrasound System

  4. Returned objects

    Source context, not route validation: Diagnostic ultrasound images and measurements plus enhanced abdominal images from 3rd Harmonic Imaging, emphasized adjacent-flow displays from SMI Angio Mode, fine-processed border displays, optimized shear-wave acquisitions, and specified gastrointestinal or airway endoscopic ultrasound images for qualified-user review.

    Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-19 · FDA K252074: Aplio i900, Aplio i800 and Aplio i700 Software V9.0 Diagnostic Ultrasound System

  5. Viewer/worklist/report

    Unresolved route: Diagnostic ultrasound images and measurements plus enhanced abdominal images from 3rd Harmonic Imaging, emphasized adjacent-flow displays from SMI Angio Mode, fine-processed border displays, optimized shear-wave acquisitions, and specified gastrointestinal or airway endoscopic ultrasound images for qualified-user review.

    Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-19 · FDA K252074: Aplio i900, Aplio i800 and Aplio i700 Software V9.0 Diagnostic Ultrasound System

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
On-premises mobile Aplio i900, i800, or i700 ultrasound console running software V9.0 on Windows 11 LTSC; endoscopic imaging requires the specified Aplio i800/E3 configuration and transducer.
  • Exact FDA submission
  • Checked 2026-09-02
Integration
The system is an on-premises ultrasound platform with site-network image exchange. Canon's current interoperability page lists an IHE integration statement for Aplio i700, i800, and i900 software V6.0 or later, covering V9.0.
  • Exact product version
  • Checked 2026-09-02

Confirm the installed IHE statement, DICOM services, endoscopic-video workflow, network routing, and downstream object support.

Security
Canon Medical's cybersecurity page states that Canon imaging systems follow a software development life cycle governed by the NIST 800-53 Risk Management Framework adhering to Defense Health Agency certification requirements; FIPS 140-2 certified cipher standards; deny-all firewall configuration and near-real-time SIEM syslog export as premium offerings; a dedicated cybersecurity risk management team for threat intelligence monitoring, advisories and incident response; and published OS and third-party update policies. Vendor statement; no certification or test report was read.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation. Identity bridge: the page is on us.medical.canon, Canon Medical's own site (Canon Medical Systems USA), and describes Canon Medical imaging devices generally; the FDA applicant is Canon Medical Systems Corporation, named in the corporate name-change press release on the same domain. Regional page with general device claims; exact-release scope is not established.

Monitoring
The 3rd Harmonic Imaging algorithm was locked after development and the FDA summary states that no postmarket continuous-learning capability is deployed on the device.
  • Exact FDA submission
  • Checked 2026-09-02

A locked model does not replace local acceptance testing, image-quality monitoring, update review, or incident escalation.

V9.0 feature package

Adds deep-learning 3rd Harmonic Imaging, SMI Angio Mode, Precision+ Fine Processing Mode, and Auto Tune for shear-wave elasticity and dispersion workflows.

exact submission · checked 2026-09-02

Confirm licensed options, compatible probes and presets, user controls, processing behavior, and output objects.

Endoscopic ultrasound configuration

The Aplio i800 TUS-AI800/E3 supports the GF-UCT180 and BF-UC190F endoscopic transducers for the specific gastrointestinal and airway indications in the FDA labeling.

exact submission · checked 2026-09-02

Verify console variant, transducer and endoscope compatibility, reprocessing workflow, accessories, and staff training.

Operating system

The FDA summary identifies Windows 11 LTSC as the operating system incorporated in the V9.0 devices, replacing Windows 10 LTSC in the predicate configuration.

exact submission · checked 2026-09-02

Confirm the exact LTSC release, patching responsibility, endpoint controls, service-access model, and vendor support lifecycle.

IHE integration documentation

Canon's current interoperability page lists an IHE integration statement for Aplio i700, i800, and i900 software V6.0 or later.

exact product version · checked 2026-09-02

Obtain and test the statement corresponding to the exact installed software build.

Deployment model

Mobile, on-premises diagnostic ultrasound console running Windows 11 LTSC; endoscopic imaging requires the specified i800/E3 configuration and transducer.

exact submission · checked 2026-09-02

Site preparation, cybersecurity controls, service access, updates, training, and downtime planning require current vendor documentation.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K252074
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Anatomy
Multi-region
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-10-31
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-19Last searched
21Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, fda device recall, vendor interoperability, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-10-27 - Exact FDA submission

    No public price or quote for the exact K252074 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Canon Aplio reimbursement CPT Medicare"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-10-27 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

7 sources - 3 history items

Source ledger

  1. FDA K252074: Aplio i900, Aplio i800 and Aplio i700 Software V9.0 Diagnostic Ultrasound System

    U.S. Food and Drug Administration - Published 2025-10-31 - Accessed 2026-09-19

    Scope: purpose, anatomy, intendedUsers, input, output, limitations, evidenceSummary

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  6. IHE integration statements for current Canon ultrasound products

    Canon Medical Systems Corporation - Accessed 2026-09-02

    Scope: integration, implementationCapabilities

  7. Canon Medical: Medical Imaging Cybersecurity

    Canon Medical Systems USA - Accessed 2026-10-26

    Scope: security

Research history

  1. K252074 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K251963

LOGIQ E10s

Ge Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: LOGIQ E10s is a general-purpose diagnostic ultrasound system supporting the labeled adult, pediatric, cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal, urologic, and procedural applications.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-29
FDA-cleared K251985

LOGIQ E10

Ge Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: LOGIQ E10 is a general diagnostic ultrasound system for qualified users across fetal and obstetric, abdominal, gynecologic, pediatric, small-organ, breast, cardiac, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, and intraoperative applications.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-29
FDA-cleared K251322

Venue; Venue Go; Venue Fit; Venue Sprint

GE Medical Systems Ultrasound and Primary care Diagnostics

Authorized purpose: Venue, Venue Go, Venue Fit, and Venue Sprint are general-purpose point-of-care ultrasound systems for trained users across broad adult, pediatric, and neonatal applications, with release-specific AI guidance and measurement functions.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-07-25

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history